Ardawi M, Badreddine S, Yasir M, Khateb A, Turkistani S, Afandi A
Front Cell Infect Microbiol. 2025; 15:1521391.
PMID: 39967793
PMC: 11832520.
DOI: 10.3389/fcimb.2025.1521391.
Heimann D, Kohnhauser D, Kohnhauser A, Bronstrup M
Drugs. 2025; 85(3):293-323.
PMID: 39847315
PMC: 11891108.
DOI: 10.1007/s40265-024-02137-x.
Srisrattakarn A, Lulitanond A, Charoensri N, Wonglakorn L, Kenprom S, Sukkasem C
Antibiotics (Basel). 2022; 11(5).
PMID: 35625328
PMC: 9137630.
DOI: 10.3390/antibiotics11050684.
Levina E, Khrenova M, Astakhov A, Tsirelson V
RSC Adv. 2022; 10(15):8664-8676.
PMID: 35496524
PMC: 9050041.
DOI: 10.1039/c9ra10649a.
Lu W, Hsu P, Lin H
Antimicrob Agents Chemother. 2021; 65(9):e0032621.
PMID: 34228542
PMC: 8370199.
DOI: 10.1128/AAC.00326-21.
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.
Bahr G, Gonzalez L, Vila A
Chem Rev. 2021; 121(13):7957-8094.
PMID: 34129337
PMC: 9062786.
DOI: 10.1021/acs.chemrev.1c00138.
Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios A, Rossi M, Mahler G, Vila A
Biomolecules. 2020; 10(6).
PMID: 32503337
PMC: 7356002.
DOI: 10.3390/biom10060854.
MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase Inhibitors.
Cheng Z, Thomas C, Joyner A, Kimble R, Sturgill A, Tran N
Biomolecules. 2020; 10(3).
PMID: 32188106
PMC: 7175331.
DOI: 10.3390/biom10030459.
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro A, Osei Sekyere J, Amoako D, Essack S, Bester L
Appl Environ Microbiol. 2018; 84(18).
PMID: 30006399
PMC: 6121990.
DOI: 10.1128/AEM.00698-18.
Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases.
Zhang D, Markoulides M, Stepanovs D, Rydzik A, El-Hussein A, Bon C
Bioorg Med Chem. 2018; 26(11):2928-2936.
PMID: 29655609
PMC: 6008492.
DOI: 10.1016/j.bmc.2018.02.043.
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?.
Domalaon R, Idowu T, Zhanel G, Schweizer F
Clin Microbiol Rev. 2018; 31(2).
PMID: 29540434
PMC: 5967690.
DOI: 10.1128/CMR.00077-17.
Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates.
Hinchliffe P, Tanner C, Krismanich A, Labbe G, Goodfellow V, Marrone L
Biochemistry. 2018; 57(12):1880-1892.
PMID: 29485857
PMC: 6007964.
DOI: 10.1021/acs.biochem.7b01299.
Cyclobutanone Mimics of Intermediates in Metallo-β-Lactamase Catalysis.
Abboud M, Kosmopoulou M, Krismanich A, Johnson J, Hinchliffe P, Brem J
Chemistry. 2017; 24(22):5734-5737.
PMID: 29250863
PMC: 5947706.
DOI: 10.1002/chem.201705886.
Insights into an evolutionary strategy leading to antibiotic resistance.
Hou C, Liu J, Collyer C, Mitic N, Pedroso M, Schenk G
Sci Rep. 2017; 7:40357.
PMID: 28074907
PMC: 5225480.
DOI: 10.1038/srep40357.
Probing the mechanisms for the selectivity and promiscuity of methyl parathion hydrolase.
Purg M, Pabis A, Baier F, Tokuriki N, Jackson C, Kamerlin S
Philos Trans A Math Phys Eng Sci. 2016; 374(2080).
PMID: 27698033
PMC: 5052733.
DOI: 10.1098/rsta.2016.0150.
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.
Brem J, Cain R, Cahill S, McDonough M, Clifton I, Jimenez-Castellanos J
Nat Commun. 2016; 7:12406.
PMID: 27499424
PMC: 4979060.
DOI: 10.1038/ncomms12406.
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P, Gonzalez M, Mojica M, Gonzalez J, Castillo V, Saiz C
Proc Natl Acad Sci U S A. 2016; 113(26):E3745-54.
PMID: 27303030
PMC: 4932952.
DOI: 10.1073/pnas.1601368113.
The Role of Active Site Flexible Loops in Catalysis and of Zinc in Conformational Stability of Bacillus cereus 569/H/9 β-Lactamase.
Montagner C, Nigen M, Jacquin O, Willet N, Dumoulin M, Karsisiotis A
J Biol Chem. 2016; 291(31):16124-37.
PMID: 27235401
PMC: 4965562.
DOI: 10.1074/jbc.M116.719005.
Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.
Wachino J, Yamaguchi Y, Mori S, Jin W, Kimura K, Kurosaki H
Antimicrob Agents Chemother. 2016; 60(7):4274-82.
PMID: 27161644
PMC: 4914674.
DOI: 10.1128/AAC.03108-15.
Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors.
Zhai L, Zhang Y, Kang J, Oelschlaeger P, Xiao L, Nie S
ACS Med Chem Lett. 2016; 7(4):413-7.
PMID: 27096051
PMC: 4834647.
DOI: 10.1021/acsmedchemlett.5b00495.